Abstract | Povezanost obiteljske anamneze na bolesti vrata maternice s odlukom o cijepljenju
protiv humanog papiloma virusa u studenata Sveučilišta u Zagrebu
Enida Sičaja
Uvod i cilj istraživanja
Humani papiloma virus (HPV) visoko je prenosivi virus i povezan je s pojavnošću
nekoliko sijela raka. Cilj ovoga rada bio je istražiti bio je ispitati obilježja studenata
cijepljenih protiv humanog papiloma virusa.
Ispitanici i metode
Za potrebe ovoga rada, analizirani su odgovori na pitanja prikupljenih upitnikom,
studenata (N=272, 79% studentica) koji su se dobrovoljno odazvali na besplatno
cijepljenje protiv HPV-a u Nastavnom zavodu za javno zdravstvo „Dr. Andrija
Štampar“, akademske godine 2016./17. Anonimizirani podatci obrađeni su metodama
deskriptivne statistike i interpretirani na razini značajnosti P<0,05.
Rezultati
Većina ispitanika nije imala kronične bolesti (79,4%) i nisu uzimali lijekove (80,1%).
Pozitivnu obiteljsku anamnezu na bolesti vrata maternice imalo ih je 18,8%. Značajno
su se više cijepili oni (76,1%) koji nisu imali pozitivnu obiteljsku anamnezu (P<0,001).
Spolno aktivno je bilo 80,8% ispitanika, a više od polovine je imalo stalnog partnera i
imalo je informaciju koliko spolnih partnera je partner imao prije njih. Studentice su
imale značajno češće dva spolna partnera (22,2% vrs. 6,4%, P=0,03), a studenti četiri
i više (48,9% vrs. 33,3%, P=0,03). Većina ispitanika je primila sva obavezna cjepiva
(97,8%), a neželjene reakcije imalo ih je 1,5%. Većina studentica bila je na
ginekološkom pregledu (83%) i imale su učinjen Papa test (69,5%). Za cijepljenje protiv
HPV-a najviše su se informirali od prijatelja (28,1%) i članova obitelji (25,2%).
Zaključak
Rezultati su pokazali da se je za cijepljenje odlučio veći broj studenata koji nisu imali
pozitivnu obiteljsku anamnezu na bolesti vrata maternice. Rezultati ukazuju na potrebu
većeg angažmana i dostupnosti zdravstvenog sustava u pružanju informacija o HPV
infekciji, s naglaskom na liječnike i medicinske sestre/tehničare u službama za školsku
i adolescentnu medicinu, koji najviše sudjeluju u provedbi cijepljenja protiv HPV. |
Abstract (english) | Relationship of family history of cervical disease with the decision to vaccinate against
human papilloma virus in students of the University of Zagreb
Enida Sičaja
Introduction and aim: human papilloma virus (HPV) is a highly transmissible virus and
it is associated with the occurrence of several cancers. The aim of this study was to
investigate the characteristics of students vaccinated against HPV.
Subjects and methods: data were collected by questionnaire answered by students
(N=272, 79% of female) who voluntarily responded to free vaccination against HPV in
Teaching Institute of Public Health "Dr. Andrija Štampar” in academic year 2016/17.
For the purpose of this study, anonymized data were processed by methods of
descriptive statistics and interpreted at a significance level of P<0.05.
Results: majority of respondents did not have chronic diseases (79.4%) and did not
take medication (80.1%). Positive family history on cervical disease had 18.8%. Those
who did not have a positive family history were significantly more vaccinated (76.1%,
P <0.001). Sexually active were 80.8% and more than a half had a permanent partner
and information on how many sexual partners partner had before. Female students
had significantly more frequent two sexual partners (22.2% vrs. 6.4%, P=0.03) and
male had four or more (48.9% vrs. 33.3%, P=0.03). The majority of respondents
received all mandatory vaccines (97.8%), and 1.5% had adverse reactions. Most of
the female students had a gynecological examination (83%) and PAPA test (69.5.%).
Respondents were informed about HPV vaccination by friends (28.1%) and family
members (25.2%).
Conclusion: results showed significantly higher number of vaccinated students without
positive family history on cervical diseases. Results imply necessity of greater
involvement and availability of the health system in providing relevant information on
HPV infection, with emphasis on doctors and nurses/technicians in schools and
adolescent medicine services, who are most involved in the implementation of HPV
vaccination. |